Benzinga | Jun 24, 2021 05:41AM EDT

UBS Initiates Coverage On Colgate-Palmolive with Buy Rating, Announces Price Target of $95

UBS analyst Peter Grom initiates coverage on Colgate-Palmolive (NYSE:CL) with a Buy rating and announces Price Target of $95.